Innovating Works

filtrando por convocatoria: HORIZON-HLTH-2022-TOOL-11-02

PRIME-CKD: Personalized Drug Response IMplementation and Evaluation in CKD Chronic Kidney Disease (CKD) is one of the major causes of death in high income countries and its prevalence is growing rapidly. New therapi...
2022-11-30 - 2027-12-31 | Financiado
OPADE: Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi... 280M of people worldwide suffers from major depressive disorders (MDD). Although a well-populated therapeutic landscape of anti-depre280M of...
2022-11-18 - 2027-05-31 | Financiado
ONCOVALUE: Implementing value based oncology care at European cancer hospitals An AI based framework for asses... ONCOVALUE will unlock the full potential of real world data (RWD) collected in European cancer hospitals and institutes to ease the decision...
2022-11-15 - 2026-11-30 | Financiado
Hypermarker: Personalised pharmacometabolomic optimisation of treatment for hypertension Hypertension, or high blood pressure (BP), is a serious medical condition, and the single biggest contributor to circulatory diseases which...
2022-12-08 - 2026-12-31 | Financiado
HT-ADVANCE: Improving treatment efficacy in hypertension by biomarker guided personalised decision support In HT-ADVANCE we aim to revolutionise personalised management of arterial hypertension (HT) by using multi-omics (MOMICS) stratification bio...
2022-11-22 - 2029-02-28 | Financiado
PoCCardio: Personalised Medicine by using an Advanced Point of Care Tool for Stratified Treatment in High Risk... Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Besides established risk factors such as elevated blood pressure, b...
2023-11-08 - 2028-11-30 | Financiado
REALM: Real world data Enabled Assessment for heaLth regulatory decision Making The overall aim of the REALM project is to create a collaborative framework for regulatory authorities, application developers, healthcare p...
2022-11-24 - 2026-12-31 | Financiado
SQUEEZE: Maximising Impact of Prescription Drugs in Rheumatoid Arthritis The SQUEEZE consortium comprehensively addressed how biomarkers can be used to optimize disease modifying antirheumatic drugs (DMARDs) for r...
2022-11-25 - 2027-11-30 | Financiado
Real4Reg: Development optimisation and implementation of artificial intelligence methods for real world data... Real-world evidence derived from real-world data (RWD) has a promising role to inform regulatory decision-making. Based on highly relevant u...
2022-11-11 - 2026-12-31 | Financiado
REDDIE: Real world evidence for decisions in diabetes Randomised controlled trials are the cornerstone of evidence-based medicine. However, the digitisation of real-world data (RWD) including da...
2022-11-22 - 2026-12-31 | Financiado